Sana’s UP421 Stem Cell Transplant Shows Promise in Type 1 Diabetes
Sana Biotechnology’s new type of stem cell transplant islet cells shows promise for a potential treatment for type 1 diabetes. The therapy, UP421 stem cell transplant enrolled patients to avoid immune rejection and produce insulin. As Per-Ola Carlsson, M.D., study principal pnvestigator, senior physician and professor at the Clinic for Endocrinology and Diabetology at Uppsala…